Binningen, Switzerland

Harry Tiemessen

This inventor holds 1 USPTO granted patent. Top assignee: Novartis Ag. Active years: 2003.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Harry Tiemessen. Retrieved from https://idiyas.com/inventor/harry-tiemessen-lspauv1m

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2003

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Harry Tiemessen

Introduction

Harry Tiemessen is a notable inventor based in Binningen, Switzerland. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work with liposomes. His expertise and creativity have led to the development of a unique patent that showcases his skills as an inventor.

Latest Patents

Harry Tiemessen holds a patent for "Allylamine-containing liposomes." This invention represents a significant advancement in the formulation of liposomal drugs, potentially enhancing their efficacy and delivery mechanisms. The patent highlights his ability to innovate within the pharmaceutical industry.

Career Highlights

Tiemessen is currently employed at Novartis AG, a leading global healthcare company. His role at Novartis allows him to collaborate with other experts in the field and contribute to groundbreaking research and development projects. His work is instrumental in advancing the company's mission to improve patient outcomes through innovative therapies.

Collaborations

Throughout his career, Harry has worked alongside esteemed colleagues such as David Bodmer and Thomas Kissel. These collaborations have fostered a dynamic environment for innovation and have led to the successful development of new pharmaceutical solutions.

Conclusion

Harry Tiemessen's contributions to the field of pharmaceuticals through his patent and work at Novartis AG exemplify the impact of innovation in healthcare. His dedication to advancing drug delivery systems is commendable and highlights the importance of inventors in shaping the future of medicine.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…